Aberrant B-cell function, which could arise from various underlying causes, is central to the pathogenesis of diverse ...

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a study finds.

Nutritionists share the best time to take vitamin B supplements, if it needs to be taken with food, its benefits and risks, ...

Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With ...